Member Info for Bladderman

Let someone else have your shares if you don't want them

Not sure about that as is NT to buy

Can't wait for our 65% increase when the herd arrive from product ready for distribution news expected in 4 weeks. Distribution news etc to come before! Looking good

Marve I think we need to remind ourselves that Cytiva have endorsed this.
ODX are awaiting validation and approval but are 3x higher in valuation (different approach to testing but still).
We're targetting an 8M test production a month which is twice as high as NCYT currently yet a tenth of their valuation
. Soon this is going to grip the market as the go to stock. Really excited about where I think this is going

Yep 100% Scart. It's a yes or no test. Just what the WHO are demanding

Every diagnostic hospital lab in the world have PCR machines. The potential here is mind blowing

Guys PCR is not an antibody or antigen test. It detects viral RNA fragments or nucleotide length like the DNA we have in our cells

Btw that's 5X more tests produced than ODX per day for perspective.

From company website. GDR advantages...

"End-point hybridisation and melt curve analysis"

"More tolerant of emerging viral mutations than other PCR technologies"
240,000 tests a day to be produced

Primers are designed to amply the RNA which allow for detection of mutations provided they are not within the forward and back primer which are very small nucleotide sequences and so the overwhelming majority of the 30 mutations will be detected using this technique as they won't be in this 10 nucleotide sequence. I would speculate and say over 95-99% will be detected especially when lengths can be from 9,000 to 29,000 nucleotides in length!!

Does NCYT's product need to be kept chilled? GDR's doesn't and probably ideal for global distribution. I think the MCap is telling here. Looking forward to our 40-60% uplift day.

Even with SPWCapital uber conservative estimates it would value the company at £220M and we are currently valued at less than £30M.
If the price test remained at £2 but production was 24 h then make that £440M - wow

The WHO doesn't recognise the antigen test (ELISA) because it indicates whether a person has had COVID (raised antibodies) which doesn't mean they can't have it again (as they indicated that it their is no evidence for future immunity)

A qPCR approach tells you weather the virus is present or not in the patients sample so is quantitative.
GDR represents the cheapest MCap for COVID RNA testing on AIM - by some distance.

The test won't be as low as £2 a person
Production will be 24 hours not 12
Cytiva will not demand 50%.
So extremely conservative in my view

Still can't believe this is not £1 plus. We are about to bring a robust COVID detection method on line at a capacity of 8 million test production a month!! Twice NCYT's production rate. Cytiva endorsement. Jeez lol

Fair enough they drop it but not letting one buy is naughty. Been NT for a while now

Nice while it's going!

Cytiva is the collaboration and they're providing the stabilizing compound for the PCR mixture (Lyostable) for our global market. Now £25M lol. Nicely discounted at the mo

Soon to be producing more 96 well test kits than NCYT - so a snip here at £29M by comparison lol. Both are going to do really well and provide much needed robust testing

Production per month